Skip to content

A study on the application of liquid chromatography-mass spectrometry combined with artificial intelligence in the analysis of plasma coenzyme Q10 content and cardiovascular disease risk assessment

A study on the application of liquid chromatography-mass spectrometry combined with artificial intelligence in the analysis of plasma coenzyme Q10 content and cardiovascular disease risk assessment

Status
Active, not recruiting
Phases
Early Phase 1
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2400093758
Enrollment
Unknown
Registered
2024-12-11
Start date
2024-12-31
Completion date
Unknown
Last updated
2024-12-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

CVD(cardiovascular disease)

Interventions

Low risk CVD group:N/A
Middle risk CVD group:N/A
High risk CVD group:N/A

Sponsors

Sichuan Taikang Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1. Age: 18 to 80 years old; 2. Healthy control group: low cardiovascular risk, no diabetes, hypertension, normal blood lipids, normal renal function; 3. Intermediate-risk group: moderate cardiovascular risk, possible diabetes mellitus or hypertension, mild dyslipidemia or mild renal function (GFR 60-89 ml/min/1.73?); 4. High-risk group: high cardiovascular risk, with diabetes and/or hypertension, significant dyslipidemia (TC>6.2 mmol/L, or LDL-C>=4.1 mmol/L), moderate renal function (GFR 30-59 ml/min/1.73?).

Exclusion criteria

Exclusion criteria: 1. Age less than 18 years old or over 80 years old; 2. Malignant tumors, systemic diseases (such as lupus erythematosus), severe psychiatric or neurodegenerative diseases (such as Alzheimer's disease); 3. Pregnant or lactating women; 4. History of acute infection or recent major surgery; 5. Poor lifestyle (such as alcoholism, drug abuse) or inability to guarantee stable follow-up.

Design outcomes

Primary

MeasureTime frame
Coenzyme Q10 content;

Secondary

MeasureTime frame
Low-density lipoprotein;Total cholesterol;Blood Pressure;BMI;

Countries

China

Contacts

Public ContactJianli Cui

Sichuan Taikang Hospital

1439471329@qq.com+86 135 4817 3509

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026